Skip to main content

VGM & ASSOCIATESHealthcare MSO

Search GO

Search GO

VGM & ASSOCIATESHealthcare MSO LEARN ABOUT VGM

Sen. Thune Lands Senate Majority Leader Role While Support for H.R.5555 and S.1294 Continues

Published in Government Relations on November 13, 2024

In a significant development, Sen. John Thune (R-SD) has been chosen as the new Senate Majority Leader, replacing Mitch McConnell. This is excellent news for the durable medical equipment (DME) industry, as Sen. Thune has been a steadfast legislative supporter of the industry.

Thune Event Thune

_{Cindy Coy of Avera and Rose Schafhauser of MAMES speak with Sen. Thune in Sioux Falls, SD (August 2024)}

Thune

_{AAHomecare Fly-In in 2016}

_{Event with Sen. Thune in Sioux Falls, SD}

_{AAHomecare Fly-In 2018}

We extend our gratitude to MAMES and DME suppliers in South Dakota for fostering this crucial relationship with Sen. Thune. Their efforts have been instrumental in securing a strong advocate for the DME industry in such a prominent position. Through their dedication and collaboration, we have been able to advance our shared goals and ensure that the needs and challenges of the DME community are effectively communicated.

Sen. Thune’s leadership in introducing DME legislation over the years to improve accessibility, particularly in rural areas, has been particularly impactful. Notably, his current Senate bill, S.1294, which extends the Medicare 75/25 blended rate for non-rural, non-CBA home medical equipment suppliers, stands out as a significant achievement.

Dear Colleague Letter Closes: Continue Supporting H.R. 5555 and S.1294 in End-of-Year Package

The Dear Colleague letter supporting H.R.5555 and S.1294 closed on Friday, Nov. 8, with 33 signatures. You can view the letter and all signatures here. Representatives Mariannette Miller-Meeks (R-IA), Paul Tonko (D-NY), and Randy Feenstra (R-IA) authored the letter, advocating for the reestablishment of the Medicare 75/25 blended rate for DME in non-rural, non-competitive bid areas for 2025.

Thank you to everyone who contacted their member(s) of Congress to support this letter. If your representative signed the letter, please send them a thank you note!

We hope that the H.R. 5555/S.1294 legislation will be included in any end-of-year package. While it remains uncertain whether such a package will be presented before the end of the year, it is crucial to advocate for this legislation now. If your representative has not yet signed on to these bills, please reach out to them today. We’ve made it easy for you! Click here to send a message to your member(s) of Congress and Senator, urging them to support H.R.5555/S.1294.

TAGS

From Our Experts

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail

HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry.

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk.

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review.

Evaluating the Value of a Payer Contract thumbnail

Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort.

Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.

The Return of Competitive Bidding thumbnail

The Return of Competitive Bidding The Centers for Medicare & Medicaid Services (CMS) appear to be laying the groundwork for another round of the Competitive Bidding Program (CBP). While full implementation will take a couple of years, an official announcement is expected this summer—potentially as early as July.

Out With The Old RAC, In With The New thumbnail

Out With The Old RAC, In With The New On April 28, 2025, CMS awarded Cotiviti GOV Services LLC, the new RAC Recovery Audit Contractor (RAC) Region 3, 4, and 5 contracts. RAC Region 3 includes the following Medicare Administrative Contractor (MAC) jurisdictions: JJ, JM, and JN. RAC Region 4 includes jurisdictions: JE, JF, and JL. And RAC Region 5 includes jurisdictions: JA, JB, JC, JD, as well as the HH/H MACs: J6, J15, JK, and JM.

Be Part of Something Bigger

Become a Member